Repurposed drugs: second time lucky

The drug discovery and development path for a new chemical entity (NCE) can take ten to 15 years and cost between $1 billion and $2 billion. ‘Repurposing’ is the practice of finding novel therapeutic indications for existing drugs. Typically the selected drug will have already been shown to be safe in patients, thereby significantly reducing the time it takes to bring the drug to market.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

INTA 2026: In-house tips on what to do in London

21 April 2026 With the start of the first-ever INTA Annual Meeting held in the UK capital just weeks away, in-house IP counsel share their favourite ways to spend downtime in the city.

Europe

IP finance gap risks startup exodus, EUIPO warns

13 April 2026 New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential funding left untapped, as structural barriers persist.

Europe

Patent office fee increases: What applicants must know

13 April 2026 Europe’s latest patent fee increases are modest at the EPO but include a rare steep hike in the UK, forcing applicants to reassess filing routes, portfolio value, and long-term cost strategies, say James Bell and Yelena Morozova.

More features

INTA 2026: In-house tips on what to do in London

Baker McKenzie strengthens IP bench with new German lead

Novo Nordisk and OpenAI strike AI deal to boost drug discovery

IP finance gap risks startup exodus, EUIPO warns

Patent office fee increases: What applicants must know

UK patent office adopts EPO standards for AI inventions

Gilead to pay up to $5bn for antibody-drug conjugates push

Closing the women's health gap offers ‘benefits for all’

Repurposed drugs: second time lucky

More on this story

Editor's picks

Editor's picks

More features